Top 50 Medical Device Startup Investors in Oceania (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Artesian VC
VC Fund
|
14 | Australia, United States, Hong Kong | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Health Care | $70k–$15M |
|
Icehouse Ventures
VC Fund
|
12 | New Zealand, United States, United Kingdom | Seed, Series A | Software, SaaS, Information Technology | $650k–$19M |
|
Uniservices
VC Fund
|
10 | New Zealand, United States, United Kingdom | Seed, Pre-Seed, Venture - Series Unknown | Health Care, Medical Device, Manufacturing | $283k–$8.4M |
|
New Zealand Growth Capital Partners
VC Fund
|
9 | New Zealand, United States, Australia | Seed, Venture - Series Unknown, Series A | Software, Information Technology, Medical Device | $435k–$17M |
|
Pacific Channel
VC Fund
|
9 | New Zealand, Australia, United States | Seed, Venture - Series Unknown, Pre-Seed | Manufacturing, Health Care, Biotechnology | $511k–$5.5M |
|
Brandon Capital
VC Fund
|
8 | Australia, United Kingdom, United States | Series A, Seed, Series B | Biotechnology, Health Care, Medical | $673k–$81M |
|
Cure Kids Ventures
VC Fund
|
7 | New Zealand | Seed, Pre-Seed, Series A | Medical Device, Manufacturing, Health Care | $999k–$9.7M |
|
Movac
VC Fund
|
6 | New Zealand, United States, Australia | Seed, Series A | Software, SaaS, E-Commerce | $1.4M–$16M |
|
Medical Research Commercialisation Fund (MRCF)
VC Fund
|
6 | Australia, United Kingdom, United States | Series A, Seed | Biotechnology, Health Care, Medical | $1.3M–$13M |
|
Brisbane Angels
VC Fund
|
5 | Australia, United States, New Zealand | Seed, Pre-Seed, Series A | Software, Information Technology, Health Care | $200k–$19M |
|
Uniseed
VC Fund
|
5 | Australia, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Manufacturing, Health Care | $471k–$22M |
|
GD1 (Global From Day One)
VC Fund
|
5 | New Zealand, United States, China | Seed, Series A, Pre-Seed | Software, Information Technology, SaaS | $600k–$16M |
|
Flying Fox Ventures
VC Fund
|
5 | Australia, New Zealand, United States | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Information Technology | $120k–$11M |
|
Global from Day One
VC Fund
|
5 | New Zealand, United States, China | Seed, Series A | Software, SaaS, Medical Device | $694k–$18M |
|
Matū Group
VC Fund
|
5 | New Zealand, Australia, United States | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Manufacturing | $337k–$25M |
|
Breakthrough Victoria
VC Fund
|
5 | Australia, United States, Philippines | Seed, Venture - Series Unknown, Series A | Health Care, Manufacturing, Biotechnology | $500k–$35M |
|
Everywhere Ventures
VC Fund
|
4 | United States, Australia, India | Pre-Seed, Seed, Series A | Software, Health Care, FinTech | $500k–$20M |
|
Flying Kiwi Angels
VC Fund
|
4 | New Zealand, United States | Seed, Angel, Pre-Seed | Software, Information Technology, Apps | $334k–$4.3M |
|
Enterprise Angels
VC Fund
|
4 | New Zealand, United States, United Kingdom | Seed, Angel | Software, Information Technology, Health Care | $229k–$4.3M |
|
Booster
VC Fund
|
4 | New Zealand, United States | Seed, Pre-Seed, Venture - Series Unknown | Biotechnology, Manufacturing, Medical Device | $157k–$6.1M |
|
Sydney Angels
VC Fund
|
4 | Australia, United States | Seed, Angel, Pre-Seed | Software, SaaS, Health Care | $120k–$1.5M |
|
Melbourne Angels
VC Fund
|
4 | Australia, United States, New Zealand | Seed, Angel | Biotechnology, Software, Information Technology | $34k–$1.3M |
|
K1W1
VC Fund
|
4 | New Zealand, United States | Seed, Series A | Software, Manufacturing, Artificial Intelligence | $520k–$18M |
|
Significant Ventures
VC Fund
|
3 | Australia, United States | Seed, Series A | Manufacturing, Software, Health Care | $77k–$8.2M |
|
IP Group
VC Fund
|
3 | United Kingdom, United States, Australia | Seed, Series A | Health Care, Biotechnology, Therapeutics | $393k–$30M |
|
Nuance Capital
VC Fund
|
3 | New Zealand, United States | Seed, Series B, Series A | Software, Manufacturing, Medical Device | $1.7M–$12M |
|
b2venture
VC Fund
|
3 | Germany, Switzerland, United Kingdom | Series A, Seed, Series B | Software, Health Care, Information Technology | $1.3M–$52M |
|
Development Bank of Wales
VC Fund
|
2 | United Kingdom, Australia, United States | Seed, Debt Financing | Software, Health Care, Manufacturing | $18k–$3.8M |
|
Flying Kiwis
VC Fund
|
2 | New Zealand | Seed | SaaS, 3D Technology, Medical Device | $5M–$5M |
|
Regal Funds Management
VC Fund
|
2 | Australia, United States, United Kingdom | Convertible Note, Series B | Software, FinTech, Financial Services | $1.9M–$30M |
|
South Australian Venture Capital Fund
VC Fund
|
2 | Australia | Seed, Series B, Series A | Health Care, Biotechnology, Internet of Things | $1M–$26M |
|
CoAct Capital
VC Fund
|
2 | Australia, New Zealand | Series A, Seed, Series B | Software, Information Technology, SaaS | $4.4M–$14M |
|
Sirius Capital
VC Fund
|
2 | China, Australia | Series A, Seed, Series C | Artificial Intelligence, Robotics, Video | $1.4M–$141M |
|
Boson Ventures
VC Fund
|
2 | Australia | Seed, Pre-Seed, Series A | Financial Services, FinTech, Payments | $650k–$3M |
|
Fund WA
VC Fund
|
2 | Australia | Seed, Series A | Medical, Health Care, Manufacturing | |
|
Left Lane Capital
VC Fund
|
2 | United States, Germany, Canada | Series A, Series B, Seed | FinTech, Financial Services, Software | $2.5M–$111M |
|
Future of Healthcare Fund - Australian Unity
VC Fund
|
2 | Australia | Series A | Health Care, Medical Device, Medical | $3.4M–$6.6M |
|
KP Rx
VC Fund
|
2 | Australia, New Zealand | Seed, Venture - Series Unknown | Health Care, Medical Device, Medical | |
|
Allan Moss
Angel
|
2 | Australia, United States, The Netherlands | Series A, Seed | Health Care, Medical Device, Biotechnology | $2.4M–$8.8M |
|
Global Health Investment Fund (GHIF)
VC Fund
|
2 | United States, India, Austria | Series B, Series C | Health Care, Biotechnology, Medical Device | $4.5M–$18M |
|
Sprint Ventures
VC Fund
|
2 | Australia, United States | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Health Care | $655k–$10M |
|
Punakaiki Fund
VC Fund
|
2 | New Zealand, United States | Seed, Series A | Software, SaaS, Information Technology | $355k–$12M |
|
SFC Capital
VC Fund
|
2 | United Kingdom, United States, Canada | Pre-Seed, Seed | Artificial Intelligence, Software, Information Technology | $131k–$2.2M |
|
Anova Capital
VC Fund
|
2 | China, Australia | Series A, Seed | Education, Rental, Travel | $1.4M–$4.6M |
|
Renew Pharmaceuticals
VC Fund
|
2 | Australia | Series A, Series B | Health Care, Biotechnology, Medical Device | $5.6M–$6M |
|
Bridgewest Ventures
VC Fund
|
2 | New Zealand | Seed | Manufacturing, Medical Device, Eyewear | $2.5M–$2.8M |
|
Clare Ventures
VC Fund
|
2 | Australia | Series A | Health Care, Medical Device | $1.2M–$4.7M |
|
Uniseed Ventures
VC Fund
|
2 | Australia, United States, United Kingdom | Series A, Seed | Biotechnology, Health Care, Manufacturing | $381k–$16M |
|
Horizons Ventures
VC Fund
|
2 | United States, United Kingdom, Canada | Series A, Series B, Seed | Biotechnology, Software, Artificial Intelligence | $1M–$110M |
|
Blackbird Ventures
VC Fund
|
1 | Australia, United States, New Zealand | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, SaaS | $34k–$35M |
| Access all 50 investors in Oceania Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, Hong Kong
Investor stats
- Total investments: 407
- Round size: Seed $101k–$5M; Pre-Seed $70k–$1M; Series A $2.3M–$15M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- LivedCX® — LIVEDCX: Advanced AI technology for contact centre leaders who must simplify complexity to create growth.
- Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
- Infiction labs — SPARC 1.2 is a solar panel robotic cleaning system designed and developed by Infiction Labs Pvt Ltd for commercial solar plants.
Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A
- Geography: New Zealand, United States, United Kingdom
Investor stats
- Total investments: 252
- Round size: Seed $650k–$4.9M; Series A $2.5M–$19M
- Lead/follow: 17% lead, 83% follow
- Last fund: Likely still investing — raised $69M in 2021
Portfolio highlights
- Hnry — Hnry automatically pays and files all taxes for contractors, freelancers, and sole traders, so they never have to think about tax again.
- Vessev — Electric hydrofoiling vessels built for commercial use. Quiet, efficient, and better for the world.
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
Auckland University's commercialisation arm
Show more...Investment focus
- Industry: Health Care, Medical Device, Manufacturing
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: New Zealand, United States, United Kingdom
Investor stats
- Total investments: 28
- Round size: Seed $694k–$5M; Pre-Seed $283k–$1.3M; Venture - Series Unknown $3.2M–$8.4M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- RosterLab — RosterLab goal is to automate every part of the rostering process for healthcare.
- Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
- Zenno Astronautics — Zenno Astronautics hardware and software products ensure satellite missions are effectively managed, guaranteeing maximum economic returns and responsible use of space.
The New Zealand Growth Capital Partners (formerly New Zealand Venture Investment Fund) was established to support early-stage technology companies and to stimulate private investment into this space.
Show more...Investment focus
- Industry: Software, Information Technology, Medical Device
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: New Zealand, United States, Australia
Investor stats
- Total investments: 81
- Round size: Seed $694k–$4.9M; Series A $3.5M–$17M; Venture - Series Unknown $435k–$6.1M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Linca — Critical metals for a circular battery supply chain
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- Scentian Bio — Scentian Bio operates as a platform that provides ultimate sensing solution.
Investing in great people solving hard problems to create a better future.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Biotechnology
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: New Zealand, Australia, United States
Investor stats
- Total investments: 52
- Round size: Seed $900k–$5M; Pre-Seed $511k–$1.6M; Venture - Series Unknown $3.2M–$5.5M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Regen — We send daily recommendations to our farmers' phones based on their own farm data, so NZ can farm smarter.
- Androgenix —
- Navi Medical Technologies — Navi Medical Technologies is a medical device development company.
Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: Australia, United Kingdom, United States
Investor stats
- Total investments: 79
- Round size: Seed $673k–$9.7M; Series A $5.2M–$81M; Series B $6.4M–$68M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $210M in 2019
Portfolio highlights
- Longas — Longas Technologies, a Next Generation Sequencing (NGS) technology developer, has provided details on its Morphoseq™ library prep and associated software technology at the ‘Sequencing, Finishing and Analysis.
- Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
- Cincera Therapeutics — Cincera Therapeutics is a privately held biotechnology company.
Investing in innovation for a healthy childhood Investing in innovation for a healthy childhood Impact investing since 2008 Portfolio Companies Invested Health Tech Products Launched Product and Service Revenue Generated Jobs Created in NZ Paediatric Patients
Show more...Investment focus
- Industry: Medical Device, Manufacturing, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: New Zealand
Investor stats
- Total investments: 12
- Round size: Seed $999k–$9.7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- ISpy Nits — ISpyNits - everything you need to get rid of lice and nits once and for all
- Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
Movac is New Zealand's most experienced technology investor and is deeply integrated into the Kiwi tech sector. We've been actively investing since 1998.
Show more...Investment focus
- Industry: Software, SaaS, E-Commerce
- Stage:Seed, Series A
- Geography: New Zealand, United States, Australia
Investor stats
- Total investments: 67
- Round size: Seed $1.4M–$4.9M; Series A $1.5M–$16M
- Lead/follow: 49% lead, 51% follow
- Last fund: Likely still investing — raised $125M in 2022
Portfolio highlights
- Hnry — Hnry automatically pays and files all taxes for contractors, freelancers, and sole traders, so they never have to think about tax again.
- LawVu — Our all-in-one connected platform enables your legal team to manage all legal matters, contracts, spend and legal operations. Book your free demo now.
- Migco Pharmaceuticals — Migco Pharmaceuticals is a pharmaceutical company focused on designed to develop new drug therapies for migraine headache.
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed
- Geography: Australia, United Kingdom, United States
Investor stats
- Total investments: 28
- Round size: Series A $1.3M–$13M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- MycRx — MecRx is a drug development company that works on new treatments for cancer and novel mechanism of action antibiotics. Using proprietary “hit identification” technology, MecRx is developing inhibitors of cMyc, a protein that is deregulated in over 50% of all human cancers. MecRx draws on the expertise of the Peter MacCallum Cancer Centre and CSIROand is headquartered in Melbourne, Australia.MecRx was founded in 2013 by an ex-pharma/biotech team. MecRx is run as a virtual company based in Melbourne, Australia and its shareholders and service providers include the Peter MacCallum Cancer Institute and CSIRO. The company secured $5m Series A investment from the MRCF (www.mrcf.com.au) and CSIRO in 2015.
- Currus Biologics — Currus Biologics develops BEAT technology to advance CAR T-cell therapy for solid tumors, aiming to improve treatment outcomes in oncology.
- Cincera Therapeutics — Cincera Therapeutics is a privately held biotechnology company.
Formed in late 2006, the Brisbane Angels Pty Ltd is a large group of private investors who actively invest in early stage technology companies, usually in South East Queensland, Australia. The members are typically active or semi-retired former senior business executives, who apart from financial input can provide much needed value adding toinvestee companies through hands-on management experience and high level business networks.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 81
- Round size: Seed $250k–$1.5M; Pre-Seed $200k–$1.4M; Series A $2M–$19M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Giftbee — Giftbee reshapes gifting for businesses and consumers. Send gifts with flexibility to accept, swap, or give forward. Manage gifting programs, reduce waste, and create meaningful impact.
- Indi — Indi supports parents’ mental well-being and helps them advocate for their children’s health.
- Ovum — Meet Ovum, the intelligent health journal mobile app designed for womankind.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Health Care
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 86
- Round size: Seed $600k–$3.5M; Series A $1.6M–$16M; Series B $471k–$22M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- DeteQt — Semiconductor chip-based quantum magnetic field sensors using diamond - navigation, mining, medical imaging
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Plasmaleap — Plasmaleap is a plasma technology company that manufactures and sells zero-emissions chemical reactors designed for industrial and energy applications. The company develops reactor systems that use plasma processes to enable chemical production and transformation without relying on conventional combustion methods. Its technology supports sectorssuch as clean fuels, chemical manufacturing, and materials processing by offering electrified reactor solutions that can be integrated into existing industrial workflows. Plasmaleap designs modular systems that allow operators to deploy plasma reactors for on-site production and conversion of feedstocks using electricity as the primary energy input. The company also provides engineering support and technical integration services to help customers incorporate its reactor technology into commercial operations. Through its plasma-based approach, Plasmaleap focuses on enabling chemical processes that align with decarbonization and emissions reduction objectives across multiple industries.
GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: New Zealand, United States, China
Investor stats
- Total investments: 68
- Round size: Seed $600k–$8.2M; Pre-Seed $860k–$11M; Series A $1.8M–$16M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Vessev — Electric hydrofoiling vessels built for commercial use. Quiet, efficient, and better for the world.
- Caruso — AI-native fund administration for private markets. Trusted by 900+ real estate, private credit, and PE funds to save time and grow AUM.
- Outlier Space — Outlier Space is an aerospace startup that builds a scalable, uncrewed, and reusable satellite platform designed to unlock access to microgravity. The company provides breakthrough infrastructure to safely return orbital payloads back to Earth. This technology allows sectors like pharmaceuticals, biotechnology, and advanced materials to manufactureand research products beyond Earth's atmospheric limits.
Flying Fox Ventures is an early stage investment firm that invests across industry and across the micro-stages of pre-seed and seed.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, New Zealand, United States
Investor stats
- Total investments: 112
- Round size: Seed $662k–$3.2M; Pre-Seed $120k–$3M; Series A $649k–$11M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Operata — Continuously measure performance to deliver the best possible customer experience.
- SPEC Toolbox — Structural timber design software for Australian engineers. Design CLT, GLT, and connections to AS1720 standards. Start your free trial and automate today.
- Teacher’s Buddy — Create lesson plans, worksheets, assessments, and more in minutes. AI-powered tools designed for educators.
GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.
Show more...Investment focus
- Industry: Software, SaaS, Medical Device
- Stage:Seed, Series A
- Geography: New Zealand, United States, China
Investor stats
- Total investments: 33
- Round size: Seed $694k–$5M; Series A $1.2M–$18M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — raised $90M in 2021
Portfolio highlights
- eVouch — eVouch is the most powerful marketing tool we've used to build an organic community. We've experienced elevated brand trust while reaching an audience we never thought possible. Using customers to market to their friends is simply genius.
- Alimetry — Gastric Alimetry brings data-driven clarity to chronic gastric symptoms, helping clinicians diagnose with confidence.
- Shuttlerock — Create attention-worthy video ads from any asset for every screen, at scale.
Investing in scalable science and deep tech start-ups in Aotearoa NZ. We operate venture capital funds that invest in science and deep tech through a hands-on, active approach.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Seed, Pre-Seed, Series A
- Geography: New Zealand, Australia, United States
Investor stats
- Total investments: 20
- Round size: Seed $473k–$2.2M; Pre-Seed $337k–$972k; Series A $2.3M–$25M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Advemto — Advemto is the manufacturer and developer of ultrafast spectroscopy systems that help researchers.
- Inhibit Coatings — Inhibit Coatings is a New Zealand based company developing novel antimicrobial and antifouling coatings.
- Captivate Technology — Captivate Technology company operates a clean-tech carbon capture platform. The platform enables cement manufacturers, geothermal power plants, and biogas producers to reduce pollution and contribute to environmental initiatives by using a metal-organic framework for CO2 adsorption as a solid-state material.
The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 55
- Round size: Seed $708k–$6.8M; Series A $4M–$35M; Venture - Series Unknown $500k–$30M
- Lead/follow: 53% lead, 47% follow
Portfolio highlights
- AlleSense — AlleSense has developed a unique and novel solution to label-free imaging, the NanoMslide.
- Mental Jam — We are a games studio dedicated to creating impactful experiences that explore mental health.
- Deftbiotech — Deftbiotech is a biotech startup developing peptide-based antifungal treatments for nail and skin infections.
Everywhere Ventures is a global pre-seed venture capital fund for founders, by founders. Click to read Everywhere VC, by Everywhere Ventures, a Substack publication with tens of thousands of subscribers.
Show more...Investment focus
- Industry: Software, Health Care, FinTech
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, Australia, India
Investor stats
- Total investments: 1093
- Round size: Seed $1.2M–$6.5M; Pre-Seed $500k–$2.6M; Series A $8M–$20M
- Lead/follow: 2% lead, 98% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Donna — Meet Donna, the AI assistant built for field sales teams. Save time, cut admin, and close more deals with less effort.
- Suma Wealth — Meet Charlie, your AI financial coach inside the SUMA app. Get personalized budgeting, savings, and investing advice in English or Spanish.
- Journey Live — Journey is shifting the way modern companies prioritize mental health. Our proactive, inclusive tools engage every employee, every day.
Flying Kiwi Angels ? Helping Kiwi Startups
Show more...Investment focus
- Industry: Software, Information Technology, Apps
- Stage:Seed, Angel, Pre-Seed
- Geography: New Zealand, United States
Investor stats
- Total investments: 28
- Round size: Seed $334k–$4.3M; Angel $592k–$918k; Pre-Seed $362k–$1.3M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- PAM NZ — Forward a school newsletter, snap a screenshot, brain-dump your to-do list - PAM turns it all into a smart shared family calendar and helps manage the family tasks and events. Set up in 2 minutes. Free trial.
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- Kai's Education — Kai's Education is an innovative force in the EdTech sector, pioneering the integration of coding, STEM, and robotics into engaging learning experiences for children. Based in Auckland, New Zealand, our mission is to ignite young minds through our award-winning educational products, including the all-in-one STEAM toolbox, Kai's Clan, andthe hybrid robot, KaiBot.Our flagship product, Kai's Clan, breaks new ground by allowing children aged seven to fifteen to learn to code with state-of-the-art technologies such as AR, VR, AI, IoT, Tinkercad, and Minecraft. KaiBot, designed for hands-on learning, uses screen-free coding cards to instill the fundamentals of coding, providing immediate feedback to enhance learning.Complemented by the Kainundrum Lite app, Kai's Education facilitates a seamless transition from tactile to advanced text-based coding, nurturing problem-solving skills and creativity. Recipient of the Smart AI Toy Award and the Common Sense Top Pick for Learning Award, Kai's Education is dedicated to equipping the next generation with the skills for tomorrow's challenges. We're not just teaching coding; we're inspiring creators.
Connecting startup business owners with angel investors to raise capital . Access a network of expertise and investment opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Angel
- Geography: New Zealand, United States, United Kingdom
Investor stats
- Total investments: 134
- Round size: Seed $306k–$4.3M; Angel $229k–$651k
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — raised $12M in 2019
Portfolio highlights
- Linca — Critical metals for a circular battery supply chain
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- Scanabull — Scanabull is a 3D vision to measure cattle live weight quickly and accurately, reducing handling stress and giving farmers, agents, and processors clear, real‑time weight data. It makes weighing easy, analysis simple, and sharing seamless for everyone who relies on live weight or carcass weight decisions.
Booster is an investment manager, superannuation and default KiwiSaver scheme provider. We offer ethical, New Zealand and specialist investment options.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Medical Device
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: New Zealand, United States
Investor stats
- Total investments: 20
- Round size: Seed $473k–$4.3M; Pre-Seed $157k–$972k; Venture - Series Unknown $158k–$6.1M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Linca — Critical metals for a circular battery supply chain
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- Wych Limited — Wych puts your financial health back in your control.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Seed, Angel, Pre-Seed
- Geography: Australia, United States
Investor stats
- Total investments: 97
- Round size: Seed $120k–$1.5M; Angel $130k–$1.1M; Pre-Seed $337k–$1.5M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- Keeyu — keeyu. is a B2B SaaS platform that continuously monitors e-commerce transactions from payment to delivery. Should any issue emerge, our system immediately notifies the customer service team, enabling proactive issue resolution before it impacts the customer, saving them from opening a support ticket. The result is an enhanced post-purchaseexperience, ensuring sales retention and reducing customer complaints.Founded in 2023, the company is headquartered in Sydney, Australia, and is dedicated to empowering businesses to deliver exceptional post-purchase experiences.
- iiShield — iiShield aims to improve patient outcomes and surgeon training in transplant surgery by providing effective organ heat protection.
- Mary Technology — Generate detailed chronologies from documents in minutes with Mary Technology. Achieve 90%+ time reduction and ensure 99%+ accuracy. Try for free.
Melbourne Angels is the most active startup investor in Victoria, one of the most active in Australia. Investing in start-ups since 2007, Melbourne Angels is committed to helping innovative founders build the next generation of our economy.
Show more...Investment focus
- Industry: Biotechnology, Software, Information Technology
- Stage:Seed, Angel
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 48
- Round size: Seed $34k–$1.3M; Angel $219k–$918k
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- Emanda — Thinking about selling your business in Australia? Emanda guides you through every step: business valuation, health check, corporate compliance, and sale process. Start with a business valuation.
- Auric Essentials — Auric - The Power of Scent. Revolutionise your well-being with Auric. Discover our state-of-the-art AI-powered AromaSphere diffuser and app, designed to personalise your aromatherapy experience.
- Bitwise Agronomy — Bitwise Agronomy uses AI to analyze crop video footage and provide growers with insights into crop health, growth, and yield potential.
K1W1 provides startups and businesses in New Zealand with early and later-stage venture investments.
Show more...Investment focus
- Industry: Software, Manufacturing, Artificial Intelligence
- Stage:Seed, Series A
- Geography: New Zealand, United States
Investor stats
- Total investments: 116
- Round size: Seed $734k–$4.1M; Series A $520k–$18M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Linca — Critical metals for a circular battery supply chain
- Hyades — Hyades is an AI-powered hyperspectral intelligence platform that offers soil and land insights.
- Appetise — MenuAid is a cheaper, flexible and more sustainable alternative to meal-kit delivery providers. We provide Kiwis with a weekly meal plan, complete with recipes and a list of ingredients that can either be self-shopped or collected/delivered from your favourite supermarkets.
Significant Ventures is an early-stage venture capital fund backing transformative technologies and the ambitious founders behind them.Founded by the Hindmarsh family, Significant Ventures invests in deep tech, applied science and research-driven innovation emerging from Australia’s leading universities and research institutions. The fundcombines capital with active, hands-on support—helping early-stage companies shape their strategy, attract talent, and access follow-on funding.With a network of expert operators, advisors and institutional partners, Significant Ventures focuses on turning high-potential ideas into globally scalable businesses. The team works closely with founders across sectors including life sciences, climate tech, AI, education and advanced manufacturing.Driven by a commitment to impact, collaboration and long-term value creation, Significant Ventures exists to build the next generation of high-growth companies that will lead Australia’s innovation economy
Show more...Investment focus
- Industry: Manufacturing, Software, Health Care
- Stage:Seed, Series A
- Geography: Australia, United States
Investor stats
- Total investments: 26
- Round size: Seed $77k–$4.8M; Series A $4.5M–$8.2M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Earthodic — Earthodic is an Australian materials science company creating functional biobased coatings. Paperbarc by Earthodic is a biobased water-resistant coating for pulped or paper products. It has better water-resistance than wax coatings, more sustainable and circular than plastic coatings. Repulpable. Re
- Hearables 3D — Scale your custom-fit volumes and solve dental lab technician shortage with AI and automation solutions.
- Visionary Machines — Superior perception for next-generation autonomy
IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Australia
Investor stats
- Total investments: 206
- Round size: Seed $393k–$8.5M; Series A $2.4M–$30M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — raised $125M in 2014
Portfolio highlights
- Eight19 — Eight19, located in Cambridge, UK, develops and manufactures plastic photovoltaics for energy harvesting, for the internet of things and for off-grid applications. Through the innovative use of industry-standard, high-volume, roll-to-roll processes and solution-based organic photoactive materials, the company has a highly cost-effective route forscaling-up its technology to supply the largest markets. Eight19 is currently producing modules on a small scale for commercial partners with applications in indoor energy harvesting for wireless sensor and controllers, signage and display, and outdoor power for portable electronics. Our plastic PV modules benefit from flexibility, thinness, light-weight and robustness.
- Slamcore — Positioning, mapping and perception | State-of-the-art visual SLAM turns sensor data into actionable, spatial understanding for your vehicles.
- Oxa — Autonomous Vehicle Software - Any Vehicle, Any Place, Any Time
Nuance Capital is a venture capital fund.
Show more...Investment focus
- Industry: Software, Manufacturing, Medical Device
- Stage:Seed, Series B, Series A
- Geography: New Zealand, United States
Investor stats
- Total investments: 16
- Round size: Seed $1.7M–$6.6M; Series A $7.3M–$12M; Series B $10M–$10M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Hectre — Award winning, simple to use orchard apps for performance and cost management optimization.
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- Zenno Astronautics — Zenno Astronautics hardware and software products ensure satellite missions are effectively managed, guaranteeing maximum economic returns and responsible use of space.
B2venture is a venture capital firm focused on early-stage investments in digital and industrial technology companies. B2venture invests EUR 100m+ per year in high-growth companies with ticket sizes from EUR 0.25m to 3.5m.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Germany, Switzerland, United Kingdom
Investor stats
- Total investments: 244
- Round size: Seed $1.3M–$9M; Series A $4M–$24M; Series B $8.3M–$52M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — raised $135M in 2021
Portfolio highlights
- Everlab — The preventative health service of the future. Detect disease early, improve wellbeing, and optimise performance.
- Flyboard — Human-level AI voice agents at a fraction of the cost. Transform your customer engagement with intelligent automation.
- Kiin Bio — Drug discovery is a system problem, where every inefficiency amplifies the next. We have the solution.
Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Debt Financing
- Geography: United Kingdom, Australia, United States
Investor stats
- Total investments: 248
- Round size: Seed $360k–$3.3M; Debt Financing $18k–$3.8M
- Lead/follow: 60% lead, 40% follow
- Last fund: May invest from a new fund soon — raised $25M in 2018
Portfolio highlights
- Wagonex — Car subscription is the new, all-inclusive, flexible alternative to leasing. No large downpayment and a single fixed monthly payment. Just add fuel and go.
- Jehu Group — The Jehu Group is a third generation family owned business with over 80 years of successful trading history.We mange our operations on a day-to-day basis through three trading subsidiaries. Each subsidiary is supported by Jehu Group Limited which provides finance, HR, technical and procurement functions.In all of our markets, we position ourselvesas a dynamic and bespoke alternative to national contractors and house builders and are proud of our strong reputation in the market place.
- Reacta Biotech — Reacta Biotech has been established to develop, manufacture and commercialise oral food challenge materials to pharmaceutical standards of Good Manufacturing Practice (GMP).
Super-seeded by new entry: Flying Kiwi Angels
Show more...Investment focus
- Industry: SaaS, 3D Technology, Medical Device
- Stage:Seed
- Geography: New Zealand
Investor stats
- Total investments: 2
- Round size: Seed $5M–$5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Formus — Formus is enabling personalized orthopedics at scale through a fusion of AI-automation with computational biomechanics. Built on 20 years of musculoskeletal research at the Auckland Bioengineering Institute, Formus 3D pre-op planning is FDA, PMDA, and TGA cleared, and has planned over 3,000 hip replacement surgeries at more than 25 sites acrossANZ, Japan, and the US. We are at the next frontier of orthopedics, combining AI-automation with patient-specific modelling of bony and soft-tissue to optimize joint replacement surgeries for each and every patient. Working in tandem with implant manufacturers, we integrate seamlessly into existing industry workflows to reduce costs and vastly increase reliability and scalability. Formus's unique capabilities empower surgeons to revolutionize personalized orthopedics at scale to improve the outcomes of every patient.
Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Convertible Note, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 82
- Round size: Series B $7M–$30M; Convertible Note $1.9M–$17M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $54M in 2022
Portfolio highlights
- Send Payments — SendFX provides cross-border payment and remittance services to individuals and SMEs.
- Firmus Technologies — Building the cloud infrastructure of tomorrow, today.
- Iondrive — Iondrive is an exploration company that provides metals. They offer products that include gold, silver, copper, and other metals. They provide services for industrial use.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!South Australian Venture Capital Fund - helping build dynamic and innovative South Australian startups / scaleups and accelerate their growth to a national and global scale.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Internet of Things
- Stage:Seed, Series B, Series A
- Geography: Australia
Investor stats
- Total investments: 13
- Round size: Seed $1M–$12M; Series A $2.3M–$20M; Series B $13M–$26M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Seonix Bio — Seonix Bio is dedicated to helping health professionals, individuals and researchers understand glaucoma risk using genetics.
- Pearler.AI — Pearler gives your team super powers to respond fast to RFP, RFI, RFQ, Security, Cyber, Risk & Grant Questionnaires.
Co:Act is an investment partnership of experienced venture investors with a network of founders.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Series A, Seed, Series B
- Geography: Australia, New Zealand
Investor stats
- Total investments: 12
- Round size: Series A $4.4M–$14M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Veyor — The leading live scheduling app for the built environment, helping dispersed teams and their suppliers plan, manage and track daily activity on an easy to use mobile and desktop platform.
- OneReg — Designed specifically for Aviation - One powerful, integrated platform delivering full operational clarity, real-time compliance and smarter insights.
- EatClub — EatClub shows you nearby restaurants, with spare tables, offering last minute deals. Receive up to 50% off your bill (including drinks!)
Sirius Capital is a venture capital firm in China that invests in technology companies.
Show more...Investment focus
- Industry: Artificial Intelligence, Robotics, Video
- Stage:Series A, Seed, Series C
- Geography: China, Australia
Investor stats
- Total investments: 11
- Round size: Seed $1.4M–$4.6M; Series A $7M–$50M; Series C $105M–$141M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Vantari VR — Virtual Reality for Healthcare
- Zenbot — Zenbot is a high-growth startup specializing in embodied intelligence infrastructure.
- Kuanfen Technology Realcome — Kuanfen Technology Realcome is a brand of AI virtual bloggers that focuses on the use of various AI technologies.
Investor for disruptors and force carrier for impact! We are an Australian Venture Capital that backs visionary founders of all backgrounds and grows exceptional deep tech or business model innovation companies to become truly transformative!
Show more...Investment focus
- Industry: Financial Services, FinTech, Payments
- Stage:Seed, Pre-Seed, Series A
- Geography: Australia
Investor stats
- Total investments: 11
- Round size: Seed $650k–$3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AI-NC — Platform to connect engineers and manufacturers, and provide them with the right tools to streamline the process.
- Catalyser — Catalyser is customizable cloud software for better employee giving. It specializes in managing and growing employee giving in the workplace by volunteering, fundraising, payroll giving, appeals, and pro bono. the company involves in increasing employee engagement and social responsibility.
- Kite Magnetics — Electric motors enabling electric aircraft of all sizes to fly further, carry more and emit less. The future of aviation is electric.
FundWA is a Western Australian venture capital fund that invests in technology-enabled innovative businesses in Western Australia.
Show more...Investment focus
- Industry: Medical, Health Care, Manufacturing
- Stage:Seed, Series A
- Geography: Australia
Investor stats
- Total investments: 12
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Enzide — Enzide is an Australian company solving plastic pollution with new super enzyme technology based on years of research
- personr — Single source of truth for AML compliance
- Hola Health — 24 hour online doctors & GP consults via telehealth appointments in 15 minutes. Get instant scripts online, medical certificate online anywhere in Australia.
Left Lane Capital is a venture capital and seed-growth equity firm that invests in high-growth internet and consumer technology businesses that are fundamental to the human condition and spirit – where customers maintain a long-term relationship with the product, platform, or service.
Show more...Investment focus
- Industry: FinTech, Financial Services, Software
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Canada
Investor stats
- Total investments: 172
- Round size: Seed $2.5M–$20M; Series A $9.4M–$40M; Series B $20M–$111M
- Lead/follow: 59% lead, 41% follow
- Last fund: Likely still investing — raised $1.4B in 2022
Portfolio highlights
- Trovy — Your home's equity, in your wallet. Trovy Lending Co. dba Trovy NMLS #2676733
- Lexroom.ai — Lexroom.ai allows lawyers to complete hours of legal research in seconds.Legal professionals spend up to 50% of their time in repetitive, low value-adding tasks. That’s why we’re building Lexroom.ai, a product that allows lawyers to complete hours of research in seconds, so they can focus on what really matters.Lexroom.ai perfectly integrateswith lawyers' daily workflow and enables them to speed up time-consuming legal research tasks while increasing output quality, so that they can focus more on value-adding activities.Lexroom.ai is building a bridge between advanced artificial intelligence technologies and legal professionals, through a product specifically tailored to their needs.
- Moove — Moove is a mobility fintech that provides revenue-based vehicle financing to mobility entrepreneurs, democratizing vehicle ownership across Africa. The company embeds its alternative credit-scoring technology onto ride-hailing, logistics, and last-mile/instant delivery platforms, which allows access to proprietary performance and revenueanalytics of mobility entrepreneurs to underwrite loans.
A fund focused on delivering long term capital growth whilst increasing the wellbeing of Australians by investing in the future healthcare needs of Australians.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 2
- Round size: Series A $3.4M–$6.6M
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Oli — Baymatob is an AI-guided solution to improve health outcomes for mothers and their babies.
- OncoRes Medical — OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons to assist with the identification of tumor and healthy tissue.OncoRes Medical is an early-stage medical device company located in Perth, Western Australia and is developing the patent-protected technology in collaboration with leadingresearchers at the University of Western Australia and the Harry Perkins Institute of Medical Research and breast cancer surgeons at the Western Australian public health system.With funding provided by the Medical Research Commercialisation Fund (MRCF), OncoRes Medical aims to develop the technology for use in clinical applications that require the real-time assessment of tissue microstructure.
KP Rx is a 100% founder-owned investment firm focusing on private and early-stage public healthcare investments in Australia and New Zealand.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Venture - Series Unknown
- Geography: Australia, New Zealand
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
- Navi Medical Technologies — Navi Medical Technologies is a medical device development company.
Allan Moss acts an adviser to Anchorage’s Investment Committee. Currently Principal of Allan Moss Investments, a private investment company, Allan retired from the role of Managing Director and Chief Executive Officer of Macquarie Group in May 2008. He was with Macquarie Group for 31 years and served as CEO from 1993 to his retirement in2008. He was also a non- executive director of CSR Ltd from 1996 to 2001.Allan graduated from Sydney University in Arts with a major in Economics and in Laws with Honours. He is also a graduate of Harvard University with a Masters Degree in Business Administration with High Distinction. Allan has received numerous industry awards and recognitions. He was twice named by Barron’s Magazine as one of the 30 most respected CEOs in the world (2006, 2007). He was appointed an Officer of the Order of Australia in 2005.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Series A, Seed
- Geography: Australia, United States, The Netherlands
Investor stats
- Total investments: 9
- Round size: Series A $2.4M–$8.8M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Skykraft — Skykraft is an Australian space services firm that specializes in smallsat constellation design, production, and operation.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Invert Robotics — Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications.
The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series B, Series C
- Geography: United States, India, Austria
Investor stats
- Total investments: 18
- Round size: Series B $7.5M–$18M; Series C $4.5M–$14M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — raised $108M in 2012
Portfolio highlights
- Monod Bio — Monod Bio l Simple. Powerful. Biosensors for Medicine & Biotech.
- CXL Ophthalmics — CXLO is developing a minimally invasive treatment for an ectatic corneal disease that can bring early intervention to millions of patients globally.
- Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Early stage Venture Capital firm based in Brisbane that's investing in next generational Australian companies that are building a better future.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States
Investor stats
- Total investments: 23
- Round size: Seed $655k–$2.4M; Series A $1.9M–$10M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Radian — Radian is an energy company that designs and installs solar and storage systems.
- Umps Health — Umps offers a 24/7 personal alarm that helps you live independently with peace of mind. Easy to use, always connected.
- Bitwise Agronomy — Bitwise Agronomy uses AI to analyze crop video footage and provide growers with insights into crop health, growth, and yield potential.
Punakaiki Fund Limited makes long-term investments into high-growth, revenue-generating New Zealand companies. The company holds 20 investments, $32.3 million in assets, and is raising money in December 2017 for further investment.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A
- Geography: New Zealand, United States
Investor stats
- Total investments: 44
- Round size: Seed $355k–$5M; Series A $1.5M–$12M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- Hectre — Award winning, simple to use orchard apps for performance and cost management optimization.
- Projectworks — Grow your firm - and your impact.Projectworks is professional services automation software built for consulting firms that want to grow - and make a difference.As a project intelligence platform, Projectworks connects time tracking, expense tracking, resource management, invoicing, and financial reporting in one live system. It gives you thevisibility to see what’s working, fix what’s not, and scale your firm with confidence.Projectworks was built by consultants who know what it’s like to lose hours to spreadsheets and billing chaos. Designed specifically for engineering, architecture, software development, and management consulting, it’s professional services automation (PSA) software that gets experts out of the admin grind and back to the work that matters.Our cloud-based PSA tool brings together everything your business needs to plan, track, forecast, and grow. By automating time tracking, expense tracking, resource planning, project financials, and real-time reporting, Projectworks frees your people to focus on solving the world’s hardest problems - not wrestling with manual processes. On average, Projectworks users grow 20% in their first year.Connect Projectworks with your existing stack - including Xero, QuickBooks Online, MYOB, Jira, Azure DevOps, and Salesforce - to eliminate double handling, align your data, and operate with confidence.We’ll help you set up for success with expert data migration, comprehensive training, and responsive ongoing support.Key featuresTime tracking software: Easy, accurate timesheets that actually get filled out. Simplify project time tracking and keep billing up to date with integrated time management software for consultants.Expense tracking: Track project spend against budget with simple, mobile-friendly expense submission. Sync approved expenses directly to Xero as bills to pay.Resource management software: Plan and allocate resources effectively. See availability, utilization, and capacity in real time with powerful resource planning tools that make project delivery predictable.Revenue forecasting & project profitability: Combine financial and resourcing data to model revenue, monitor utilization and profitability, and make confident growth decisions.Invoicing automation: Create pre-populated invoices that sync seamlessly with Xero, reducing admin and helping you get paid faster.Reporting & insights: Access real-time dashboards, project profitability reports, and PSA analytics that bring clarity to every decision. Track the consulting metrics that matter most - across projects, clients, and teams.Integrations: Connect your favorite tools and run your firm on a unified project management and financial reporting platform.Flexible pricing means you only pay for what you use - plus, get a 10% discount on annual subscriptions.
- Sea-Flux Vessel Management Software — Sea-Flux is a cloud-based vessel management software package focused on simplifying and streamlining maritime operations. Our mobile-friendly app provides unparalleled features that reduce risk and cost to your operation.
Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Pre-Seed, Seed
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 578
- Round size: Seed $131k–$2.2M; Pre-Seed $173k–$846k
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $1.9M in 2019
Portfolio highlights
- Keylr — Services partner for property managers. Book reliable, top-rated professionals for your properties with e-props.
- Furbnow — Furbnow - Your companion for home improvements for the future
- Checkboard — Complete your identity verification and payments without the paperwork. Checkboard handles your ID, open banking, and payments from one app.
Anova Capital focus on investment in education, big health and new consumption.
Show more...Investment focus
- Industry: Education, Rental, Travel
- Stage:Series A, Seed
- Geography: China, Australia
Investor stats
- Total investments: 4
- Round size: Seed $1.4M–$4.6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Qukoucai — Qukoucai is an online interactive learning platform for children and children. It focuses on providing customized online personal eloquence courses for 4-12 years old children. It includes a complete closed-loop product of teaching, practice, evaluation and display, and is committed to improving children's eloquence. ability.
- Vantari VR — Virtual Reality for Healthcare
- Woody Library — Woody Library is the first subscription-based book sharing and rental platform in China. In the cabin, you can spend the least amount of money, read the most books, and never again, the book that bought the hand has turned over a few pages and found that it has no long-term collection value.
Renew Pharmaceuticals is an healthcare company.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B
- Geography: Australia
Investor stats
- Total investments: 3
- Round size: Series A $5.6M–$6M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
Bridgewest Ventures is a venture capital company that invests in start-ups commercialized on a global scale.
Show more...Investment focus
- Industry: Manufacturing, Medical Device, Eyewear
- Stage:Seed
- Geography: New Zealand
Investor stats
- Total investments: 3
- Round size: Seed $2.5M–$2.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Luminoma — Luminoma will enable easy access to objective and precise skin cancer screening. With Luminoma, clinicians can confidently discern malignant from benign, reducing unnecessary referrals and biopsies.
- TheiaNova — TheiaNova provides nonsurgical therapies to patients with vision impairment due to ecstatic vision disorders. A patient suffering from keratoconus will undergo therapeutic remodeling of the cornea with the company's therapy, allowing healthcare professionals to focus on correcting vision impairments with glasses and corrective lenses orhalting progression of the disease with corneal crosslinking.
- Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
Clare Ventures provides the capital female-founded businesses deserve to innovate, scale and create lasting impact.
Show more...Investment focus
- Industry: Health Care, Medical Device
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 2
- Round size: Series A $1.2M–$4.7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Oli — Baymatob is an AI-guided solution to improve health outcomes for mothers and their babies.
Uniseed is Australia's first, and longest running, university owned venture fund. Established in 2000, we are owned by 9 universities plus CSIRO (behind over 60% of Australia's research) and fund deep-tech spinouts through to global scale.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Seed
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 57
- Round size: Seed $381k–$4.2M; Series A $1.3M–$16M
- Lead/follow: 12% lead, 88% follow
- Last fund: May invest from a new fund soon — raised $14M in 2017
Portfolio highlights
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com
Investing in the deep science and technology that can propel humanity towards a radically better future.
Show more...Investment focus
- Industry: Biotechnology, Software, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 274
- Round size: Seed $1M–$11M; Series A $6.2M–$47M; Series B $10M–$110M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- Onavo — Onavo, founded 2010, is the company behind Onavo Insights, the largest mobile intelligence service, and the developer of the award-winning Onavo mobile utility apps.Onavo Insights market intelligence data, powered by fully anonymized data from Onavo's apps, powers business decisions in companies in verticals diverse as finance, gaming,entertainment and social networking, and reports are cited regularly in the press as the primary barometer of the mobile app ecosystem.
- Magisto — Magisto online video editor is a fast & powerful video maker. Turn your photos and video clips into video stories with Magisto movie editor. Start free!
- Corephotonics — Corephotonics is the pioneer and worldwide market leader of dual camera technologies for smartphones and mobile devices, providing a perfect mobile camera photography experience, novel photography features and superior image quality
Blackbird is a venture capital fund based in Australia and New Zealand. We invest in every type of technology from software to space, unified by the biggest of ambitions.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 324
- Round size: Seed $34k–$7.2M; Pre-Seed $50k–$2.7M; Series A $3.4M–$35M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Canva — Canva is a graphic design software solutions provider that helps users to design presentations, social media graphics, and more with various layouts, images, photo filters, icons and shapes, and fonts. The platform combines a drag-and-drop design tool with a stock library of photographs, illustrations, and imagery.It was founded in 2012 andheadquartered in Sydney, New South Wales.
- Foundry Lab — Foundry Lab is pioneering Digital Metal Casting. This new form of additive manufacturing allows users to cast metal parts - without pouring molten metal - in the safety of their own office. This fully automated system is incredibly fast - CAD file to 50+ metal parts in just 8 hours.
- Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device Investors in Oceania investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 investors investing in Oceania Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!